129 related articles for article (PubMed ID: 38335726)
21. Nicotinic acetylcholine receptors: Therapeutic targets for novel ligands to treat pain and inflammation.
Hone AJ; McIntosh JM
Pharmacol Res; 2023 Apr; 190():106715. PubMed ID: 36868367
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotection of rat retinal ganglion cells mediated through alpha7 nicotinic acetylcholine receptors.
Iwamoto K; Mata D; Linn DM; Linn CL
Neuroscience; 2013 May; 237():184-98. PubMed ID: 23402849
[TBL] [Abstract][Full Text] [Related]
23. The Antinociceptive and Anti-Inflammatory Properties of the
Quadri M; Bagdas D; Toma W; Stokes C; Horenstein NA; Damaj MI; Papke RL
J Pharmacol Exp Ther; 2018 Nov; 367(2):203-214. PubMed ID: 30111636
[TBL] [Abstract][Full Text] [Related]
24. α7 and β2 Nicotinic Acetylcholine Receptor Subunits Form Heteromeric Receptor Complexes that Are Expressed in the Human Cortex and Display Distinct Pharmacological Properties.
Thomsen MS; Zwart R; Ursu D; Jensen MM; Pinborg LH; Gilmour G; Wu J; Sher E; Mikkelsen JD
PLoS One; 2015; 10(6):e0130572. PubMed ID: 26086615
[TBL] [Abstract][Full Text] [Related]
25. Coexpression and spatial association of nicotinic acetylcholine receptor subunits alpha7 and alpha10 in rat sympathetic neurons.
Lips KS; König P; Schätzle K; Pfeil U; Krasteva G; Spies M; Haberberger RV; Grando SA; Kummer W
J Mol Neurosci; 2006; 30(1-2):15-6. PubMed ID: 17192608
[TBL] [Abstract][Full Text] [Related]
26. Nicotinic acetylcholine receptors regulate vestibular afferent gain and activation timing.
Morley BJ; Lysakowski A; Vijayakumar S; Menapace D; Jones TA
J Comp Neurol; 2017 Apr; 525(5):1216-1233. PubMed ID: 27718229
[TBL] [Abstract][Full Text] [Related]
27. A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
McIntosh JM; Plazas PV; Watkins M; Gomez-Casati ME; Olivera BM; Elgoyhen AB
J Biol Chem; 2005 Aug; 280(34):30107-12. PubMed ID: 15983035
[TBL] [Abstract][Full Text] [Related]
28. Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptors.
Briggs CA; Grønlien JH; Curzon P; Timmermann DB; Ween H; Thorin-Hagene K; Kerr P; Anderson DJ; Malysz J; Dyhring T; Olsen GM; Peters D; Bunnelle WH; Gopalakrishnan M
Br J Pharmacol; 2009 Nov; 158(6):1486-94. PubMed ID: 19845675
[TBL] [Abstract][Full Text] [Related]
29. Analogs of α-conotoxin PnIC selectively inhibit α7β2- over α7-only subtype nicotinic acetylcholine receptors via a novel allosteric mechanism.
George AA; John SJ; Lucero LM; Eaton JB; Jaiswal E; Christensen SB; Gajewiak J; Watkins M; Cao Y; Olivera BM; Im W; McIntosh JM; Whiteaker P
FASEB J; 2024 Jan; 38(1):e23374. PubMed ID: 38161283
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological profiles and anti-inflammatory activity of pCN-diEPP and mCN-diEPP, new alpha9alpha10 nicotinic receptor ligands.
Richter K; Herz SM; Stokes C; Damaj MI; Grau V; Papke RL
Neuropharmacology; 2023 Dec; 240():109717. PubMed ID: 37758018
[TBL] [Abstract][Full Text] [Related]
31. Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1.
Indurthi DC; Pera E; Kim HL; Chu C; McLeod MD; McIntosh JM; Absalom NL; Chebib M
Biochem Pharmacol; 2014 May; 89(1):131-40. PubMed ID: 24548457
[TBL] [Abstract][Full Text] [Related]
32. Attenuation in Nicotinic Acetylcholine Receptor α9 and α10 Subunit Double Knock-Out Mice of Experimental Autoimmune Encephalomyelitis.
Liu Q; Li M; Whiteaker P; Shi FD; Morley BJ; Lukas RJ
Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31817275
[TBL] [Abstract][Full Text] [Related]
33. Nicotine inhibits Fc epsilon RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through alpha 7/alpha 9/alpha 10-nicotinic receptors.
Mishra NC; Rir-sima-ah J; Boyd RT; Singh SP; Gundavarapu S; Langley RJ; Razani-Boroujerdi S; Sopori ML
J Immunol; 2010 Jul; 185(1):588-96. PubMed ID: 20505147
[TBL] [Abstract][Full Text] [Related]
34. Contrasting properties of α7-selective orthosteric and allosteric agonists examined on native nicotinic acetylcholine receptors.
Gill JK; Chatzidaki A; Ursu D; Sher E; Millar NS
PLoS One; 2013; 8(1):e55047. PubMed ID: 23383051
[TBL] [Abstract][Full Text] [Related]
35. Auto/paracrine control of inflammatory cytokines by acetylcholine in macrophage-like U937 cells through nicotinic receptors.
Chernyavsky AI; Arredondo J; Skok M; Grando SA
Int Immunopharmacol; 2010 Mar; 10(3):308-15. PubMed ID: 20004742
[TBL] [Abstract][Full Text] [Related]
36. Molecular interaction of α-conotoxin RgIA with the rat α9α10 nicotinic acetylcholine receptor.
Azam L; Papakyriakou A; Zouridakis M; Giastas P; Tzartos SJ; McIntosh JM
Mol Pharmacol; 2015 May; 87(5):855-64. PubMed ID: 25740413
[TBL] [Abstract][Full Text] [Related]
37. Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist.
Whiteaker P; Christensen S; Yoshikami D; Dowell C; Watkins M; Gulyas J; Rivier J; Olivera BM; McIntosh JM
Biochemistry; 2007 Jun; 46(22):6628-38. PubMed ID: 17497892
[TBL] [Abstract][Full Text] [Related]
38. An Evolving Therapeutic Rationale for Targeting the α
Deutsch SI; Burket JA
Curr Top Behav Neurosci; 2020; 45():167-208. PubMed ID: 32468495
[TBL] [Abstract][Full Text] [Related]
39. In vitro binding characteristics of [3H]AZ11637326, a novel alpha7-selective neuronal nicotinic receptor agonist radioligand.
Gordon JC; Phillips E; Gurley DA; Heys JR; Lazor LA; Barthlow HG; Mallamaci MA; Keith RA
Eur J Pharmacol; 2010 Oct; 645(1-3):63-9. PubMed ID: 20674564
[TBL] [Abstract][Full Text] [Related]
40. Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations.
Williams DK; Wang J; Papke RL
Biochem Pharmacol; 2011 Oct; 82(8):915-30. PubMed ID: 21575610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
